Tanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation

Oncotarget. 2017 May 9;8(19):31915-31922. doi: 10.18632/oncotarget.16651.

Abstract

Oxidative stress and inflammation have been demonstrated to be involved in the onset and promotion of diabetic nephropathy (DN).Tanshinone IIA (Tan) possesses both antioxidant and anti-inflammatory properties. Here, the aim of the present study was to explore whether Tan could attenuate renal damage in the rats with streptozotocin (STZ)-induced diabetes and its potential mechanisms. Tan was gavaged to STZ-induced diabetic rats at the dose of 10mg/kg once a day for 12 weeks. Tan treatment significantly attenuated albuminuria and renal histopathology in diabetic rats. Besides, Tan treatment also effectively inhibited oxidative stress and inflammatory reaction in the kidneys of diabetic rats. Our study provided evidence that the protective effect of Tan on diabetes-induced renal injury is associated with inhibition of oxidative stress and inflammation. Tan may be a potential candidate for the treatment of DN.

Keywords: diabetes; kidney; tanshinone.

MeSH terms

  • Abietanes / pharmacology*
  • Albuminuria / drug therapy
  • Albuminuria / etiology
  • Albuminuria / metabolism
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Biomarkers
  • Blood Glucose / drug effects
  • Diabetes Mellitus, Experimental
  • Diabetic Nephropathies / drug therapy
  • Diabetic Nephropathies / metabolism*
  • Diabetic Nephropathies / pathology*
  • Inflammation / drug therapy
  • Inflammation / metabolism*
  • Inflammation / pathology*
  • Inflammation Mediators
  • Kidney Function Tests
  • Male
  • Oxidative Stress / drug effects*
  • Rats

Substances

  • Abietanes
  • Anti-Inflammatory Agents, Non-Steroidal
  • Biomarkers
  • Blood Glucose
  • Inflammation Mediators
  • tanshinone